期刊文献+

寻找阿尔茨海默病的易患基因 被引量:4

原文传递
导出
摘要 阿尔茨海默病(Alzheimer's disease,AD)是一种以进行性认知功能障碍和行为损害为特征的中枢神经系统退行性病变,是老年期痴呆的最常见类型.然而其确切病因及发病机制尚不清楚.目前认为,AD是一种由环境和遗传因素共同作用的多基因病.AD可分为家族性AD(或称为早发性AD,early-onset?AD, EOAD)和散发性AD(或称为迟发性AD,late-onset AD, LOAD)[1].早期研究显示,β-淀粉样前体蛋白(APP)基因、早老素-1基因、早老素-2基因为EOAD的主要致病基因,而载脂蛋白E(ApoE)基因是近20年来唯一公认的LOAD易患基因.
出处 《中华神经科杂志》 CAS CSCD 北大核心 2014年第2期128-132,共5页 Chinese Journal of Neurology
基金 国家自然科学基金资助项目(81000544,81171209,81371406) 山东省自然科学基金资助项目(ZR2010HQ004,ZR2011HZ001)
  • 相关文献

参考文献43

  • 1卢晓雄,吕清,浦佳丽,张宝荣.阿尔茨海默病患者早老素-1基因突变检测及其突变后对早老素-1和淀粉样前体蛋白表达功能的影响[J].中华神经科杂志,2013,46(1):5-9. 被引量:7
  • 2Rogaeva E, Meng Y, Lee JH, et al. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease [J]. Nat Genet, 2007,39: 168-177.
  • 3Beecham GW, Martin ER, Li YJ, et al. Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease[ J]. Am J Hum Genet, 2009, 84: 35-3.
  • 4Seshadri S, Fitzpatrick AL, lkram MA, et al. Genome-wide analysis of genetic' loci associated with Alzheimer disease [ J ]. JAMA, 2010, 303: 1832-1840.
  • 5Naj AC, Jun G, Beecham GW, et al. Common variants at MFIA4/MS4A6E, CD2AP, CD33 and EPHAI are associated with ate-onset Alzheimer' s disease[ J]. Nat Genet, 2011, 4-3 : 436-441.
  • 6Reitz C, Cheng R, Rogaeva E, et al. Meta-analysis of the association between variants in SORLI and Alzheimer disease[ J ]. Arch Neurol, 2011, 68: 99-106.
  • 7Harold D, Abraham R, Hollingworth P, et ',d. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer' s disease [ J ]. Nat Genet, 2009, 41 : 1088-1093.
  • 8Carrasquillo MM, Belbin O, Hunter TA, et al. Replication of BINI association with Alzheimer' s disease and evaluation of genetic interactions[J]. J Alzheimers Dis, 2011, 24: 751-758.
  • 91.ambert JC, Zelenika D, Hihunen M, et al. Evidenee of the association of BINI and PICALM with the AD risk in contrasting European populations[ J ]. Neurobiol Aging, 2011, 32 : 756 el l- el5.
  • 10Hollingworth P, Harold D, Sims R, et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHAI, CD33 and CD2AP are associated with Alzheimer' s disease[ J]. Nat Genet, 2011, 43 : 429-435.

二级参考文献54

  • 1刘红,张本恕,张天林.视神经脊髓炎一家系二例[J].中华神经科杂志,2006,39(8):535-535. 被引量:3
  • 2Ferri CP, Prince M, Brayne C, et al. Global prevalence of dementia: a Delphi consensus study. Lancet, 2005,366:2112- 2117.
  • 3Bertram I,, l,ill CM, Tanzi RE. The genetics of Alzheimer disease : back to the future. Neuron,2010,68:270-281.
  • 4Tanzi RE, Bertram L. Twenty years of the Alzheimer' s disease amyloid hypothesis: a genetic perspective. Ce11,2005 120 545- 555.
  • 5Goate A, Hardy J. Twenty years of Alzheimer' s disease-causing mutations. J Neurochem,2012,120 Suppl 1:3-8.
  • 6Bertram I,, Mcqueen MB, Mullin K, et al. Systematic meta- analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet,2007,39:17-23.
  • 7Tanahashi H, Kawakatsu S, Kaneko M, et al. Sequence analysis of presenilin-1 gene mutation in Japanese Alzheimer' s disease patients. Neurosci Lett, 1996,218 : 139 - 141.
  • 8Scacchi R, Gambina G, Moretto G, et al. A mutation screening by DHPLC of PSEN1 and APP genes reveals no significant variation associated with the sporadic late-onset form of Alzheimer' s disease. Neurosci Lett,2007,418 : 282-285.
  • 9Mekhann G, Draehman D, Folstein M, et al. Clinical diagnosis of Alzheimer' s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Fleahh anti Human Serviees Task Force on Alzheimer' s Disease. Neurology, 1984,34: 939- 944.
  • 10Dubois B, Feldman HH, Jacova C, et al. Research criteria for the diagnosis of Alzheimer' s disease: revising the NINCDS- ADRDA criteria, l,ancet Neurol,2007,6:734-746.

共引文献9

同被引文献49

  • 1刘兴彦,尹利德,段勇,王玉明,程宝文,王燕.家族性阿尔茨海默病早老素-1基因突变研究[J].中华医学遗传学杂志,2004,21(5):455-458. 被引量:4
  • 2Iqbal K, Bolognin S, Wang X, et al. Animal models of the sporadic form of Alzheimer' s disease: focus on the disease and not just the lesions [J]. J Alzheimers Dis, 2013, 37(3) : 469-474.
  • 3Obulesu M, Rao DM. Animal models of Alzheimer' s disease: an understanding of pathology and therapeutic avenues [ J ]. Int J Neurosci, 2010, 120(8) : 531-537.
  • 4Woodruff-Pak DS. Animal models of Alzheimer' s disease: therapeutic implications [ J]. J Alzheimers Dis, 2008, 15 (4) : 507-521.
  • 5Kaushal A, Wani WY, Anand R, et al. Spontaneous and induced nontransgenic animal models of ad : Modeling AD using combinatorial approach [ J]. Am J Alzheimers Dis Other Demen, 2013, 28(4) : 318-326.
  • 6Butterfield DA, Poon HF. The senescence-accelerated prone mouse ( SAMP8 ) : a model of age-related cognitive decline with relevance to alterations of the gene expression and protein abnormalities in Alzheimer' s disease [ J]. Exp Gerontol, 2005, 40(10) : 774-783.
  • 7Rowan MJ, Klyubin I, Cullen WK, et al. Synaptic plasticity in animal models of early Alzheimer' s disease [ J ]. Philos Trans R Soc Lond B Biol Sci, 2003, 358(1432) : 821-828.
  • 8Terry AV Jr, Buccafusco JJ. The cholinergic hypothesis of age and Alzheimer' s disease-related cognitive deficits: recent challenges and their implications for novel drug development [ J ]. J Pharmacol Exp Ther, 2003, 306 (3) : 821-827.
  • 9Broks P, Preston GC, Traub M, et al. Modelling dementia: effects of scopolamine on memory and attention [ J l- Neuropsychologia, 1988, 26 (5) : 685-700.
  • 10Ebert U, Kirch W. Scopolamine model of dementia: electroencephalogram findings and cognitive performance [ J ]. Eur Journal Clin Invest, 1998, 28( 11 ) : 944-949.

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部